GSK plc (LSE/NYSE:GSK) has announced its plans to move to its global headquarters to a new building in central London in 2024.
The company is currently based in Brentford, a suburban town in West London.
GSK isn’t the only Big Pharma company to announce a headquarters change. In late November, Sanofi (Nasdaq:SNY) moved its home base to Paris’s 17th arrondissement neighborhood.
The company terms its new six-storied headquarters as the ‘Earnshaw.’
Approximately 3,000 employees will be based at the site. It will have offices for the company’s C-suite. It will also have space for the company’s R&D team, and employees focused on the supply chain, operations, corporate functions and HIV-focused ViiV Healthcare, a joint venture with Pfizer and Shionogi.
The headquarters will be a hybrid working environment.
Construction of the Earnshaw building is slated for completion in 2023.
GSK spun out its consumer division, which it branded…